Radiometals for Diagnostic Imaging and Theranostics

radiopharmaceutical used in diagnostic imaging and theranostics

The first radiometal molybdenum-99/technetium-99m generator was developed at the Brookhaven National Laboratory in 1959, subsequently, in 1964, technetium-99m radiotracers were being established at the Argonne National Laboratory.  Currently, 85% of radiopharmaceuticals use technetium-99m based imaging agents.  These imaging agents can be used to evaluate organ function, detect cancer, measure blood flow and follow metabolic processes. Continue reading

What is Myocardial perfusion imaging of the heart

Spect Imaging- Myocardial Perfusion

Technetium-99m Myocardial Perfusion Scan

The most commonly used medical radioisotope in diagnostic procedures is the metastable nuclear isomer of technetium-99 and is known as technetium-99m (Tc-99m). Continue reading